EP 1414428 A1 20040506 - HISTONE DEACETYLASE ENZYME-INHIBITING DERIVATIVES OF HYDROXAMIC ACID AS NEW CYTOKINE SYNTHESIS-INHIBITING ANTI-INFLAMMATORY DRUGS
Title (en)
HISTONE DEACETYLASE ENZYME-INHIBITING DERIVATIVES OF HYDROXAMIC ACID AS NEW CYTOKINE SYNTHESIS-INHIBITING ANTI-INFLAMMATORY DRUGS
Title (de)
HISTON DEAZETYLASE ENZYM-HEMMENDE HYDROXAMSÄUREDERIVATE ALS NEUE ENTZÜNDUNGSHEMMER ZUR HEMMUNG DER ZYTOKINSYNTHESE
Title (fr)
DERIVES DE L'ACIDE HYDROXAMIQUE INHIBITEURS DE L'ENZYME HISTONE DEACETYLASE UTILISES COMME NOUVEAUX MEDICAMENTS ANTI-INFLAMMATOIRES INHIBITEURS DE LA SYNTHESE DE LA CYTOKINE
Publication
Application
Priority
- EP 0208379 W 20020726
- IT MI20011733 A 20010807
Abstract (en)
[origin: WO03013493A1] The use of derivatives of hydroxamic acid having histone deacetylase enzyme-inhibiting activity for the preparation of anti-inflammatory medicaments is disclosed.
IPC 1-7
A61K 31/166; A61P 19/02; A61P 25/02; A61P 29/00; A61P 1/04; A61P 9/10; A61P 11/00; A61P 11/06; A61K 31/165
IPC 8 full level
A61P 1/00 (2006.01); A61K 31/16 (2006.01); A61K 31/165 (2006.01); A61K 31/166 (2006.01); A61K 31/167 (2006.01); A61P 1/04 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 25/00 (2006.01); A61P 25/02 (2006.01); A61P 29/00 (2006.01); A61P 31/12 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR US)
A61K 31/165 (2013.01 - EP US); A61K 31/166 (2013.01 - EP KR US); A61K 31/167 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 03013493A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated extension state (EPC)
MK RO SI
DOCDB simple family (publication)
WO 03013493 A1 20030220; WO 03013493 A8 20040226; AT E435013 T1 20090715; BR 0212014 A 20040803; CA 2456533 A1 20030220; CN 1538838 A 20041020; CY 1109391 T1 20140702; DE 60232797 D1 20090813; DK 1414428 T3 20090831; EP 1414428 A1 20040506; EP 1414428 B1 20090701; ES 2328468 T3 20091113; HU P0401167 A2 20041129; IL 160075 A0 20040620; IS 7124 A 20040126; IT MI20011733 A0 20010807; IT MI20011733 A1 20030207; JP 2005506320 A 20050303; KR 20040035724 A 20040429; MX PA04001190 A 20050217; NO 20040513 L 20040324; PL 365391 A1 20050110; PT 1414428 E 20090825; RU 2004106605 A 20050510; SI 1414428 T1 20091031; US 2004157930 A1 20040812
DOCDB simple family (application)
EP 0208379 W 20020726; AT 02764796 T 20020726; BR 0212014 A 20020726; CA 2456533 A 20020726; CN 02815436 A 20020726; CY 091100978 T 20090921; DE 60232797 T 20020726; DK 02764796 T 20020726; EP 02764796 A 20020726; ES 02764796 T 20020726; HU P0401167 A 20020726; IL 16007502 A 20020726; IS 7124 A 20040126; IT MI20011733 A 20010807; JP 2003518503 A 20020726; KR 20047001946 A 20020726; MX PA04001190 A 20020726; NO 20040513 A 20040129; PL 36539102 A 20020726; PT 02764796 T 20020726; RU 2004106605 A 20020726; SI 200230840 T 20020726; US 48615204 A 20040409